Clinical Trial Update: Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of levetiracetam for social anxiety disorder (generalized type) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Anxiety Disorders | Phase 2 | Status: COMPLETED